抗菌成分市場：タイプ別、エンドユーザー別-2025～2030年の世界予測

抗菌成分市場は、2023年に44億2,000万米ドルと評価され、2024年には47億米ドルに達すると予測され、CAGR 6.79％で成長し、2030年には70億米ドルに達すると予測されています。

抗菌成分の範囲と定義には、細菌、ウイルス、真菌などの微生物の増殖を抑制する化合物が含まれます。これらの成分は、医薬品、飲食品、パーソナルケア、医療セグメントの製品の安全性と有効性を維持する上で極めて重要です。その必要性は、衛生と安全に対する意識の高まり、感染症の流行、製品配合を管理する厳しい規制基準によって強調されています。これらの成分の用途は幅広く、病院、食品加工装置、消費財製造などの多様な最終用途産業における殺菌剤、防腐剤、治療に及んでいます。市場洞察によると、主要成長要因としては、天然でサステイナブル抗菌ソリューションに対する需要の急増、成分合成の技術進歩、活発な研究開発活動などが挙げられます。また、COVID-19の大流行は、衛生対策の強化や消費者の健康意識の高まりにより市場需要を増大させ、市場参入企業や既存企業が製品ポートフォリオを革新・拡大する大きな機会をもたらしています。しかし、規制上のハードル、従来の抗菌薬に対する微生物の耐性新興国市場の開拓、化学品をベースとする選択肢の副作用や毒性の可能性といった課題もあります。特に、規制の枠組みが厳しい地域では、製品の承認や商業化の妨げとなる可能性があります。成長機会を活用するために、企業は天然抗菌剤の革新的な用途に焦点を当て、持続可能で毒性の低い代替品の研究に投資し、戦略的パートナーシップを結んで世界の事業展開を図る必要があります。さらに、有効性を向上させるための技術力を強化し、多機能抗菌剤を開発することで、競合を高めることができます。同市場は、環境に優しく消費者に安全な製品へのシフトを特徴としており、生分解性抗菌剤や植物由来抗菌剤の技術革新と研究が有利なフロンティアであることを示しています。

市場力学：急速に進化する抗菌成分市場の主要市場洞察を公開

抗菌成分市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 健康と衛生問題に関する意識の高まり
  • 除菌剤と表面殺菌剤に対する需要の高まり
  • 可処分所得の増加と抗菌化粧品の採用率上昇
• 市場抑制要因
  • 抗菌成分の原料と製剤に関連するコストの上昇
• 市場機会
  • 植物由来の抗菌製品への傾斜
  • 新規開発抗菌成分の上市
• 市場課題
  • 抗菌成分の厳しい承認プロセス

ポーターのファイブフォース：抗菌成分市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、抗菌成分市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：抗菌成分市場における外部からの影響の把握

外部マクロ環境要因は、抗菌成分市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：抗菌成分市場における競合情勢の把握

抗菌成分市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：抗菌成分市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、抗菌成分市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：抗菌成分市場における成功への道筋を描く

抗菌成分市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 健康と衛生問題に関する意識の向上
    • 消毒剤と表面消毒剤の需要増加
    • 可処分所得の増加と抗菌化粧品の採用増加
  • 抑制要因
    • 原料や抗菌成分の配合に関連するコストの上昇
  • 機会
    • 植物由来の抗菌製品への傾向
    • 新しく開発された抗菌成分の発売
  • 課題
    • 抗菌成分の厳格な承認プロセス
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 抗菌成分市場：タイプ別

• イントロダクション
• 無機
• 有機

第7章 抗菌成分市場：エンドユーザー別

• イントロダクション
• 自動車・輸送
• 建築・建設
• 飲食品
• 医療
• 繊維

第8章 南北アメリカの抗菌成分市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の抗菌成分市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの抗菌成分市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Ashland Global Holdings Inc
• Avient Corporation
• BASF SE
• BioCote Limited
• Clariant AG
• Croda International PLC
• Destiny Pharma PLC
• DuPont de Nemours, Inc.
• HeiQ PLC
• Kemin Industries, Inc.
• Lonza Group AG
• LyondellBasell Industries Holdings B.V.
• Merck KGaA
• Microban International, Ltd.
• Milliken & Company
• Momentive Performance Materials Inc
• NATUREX SA
• Nouryon Chemicals Holding B.V.
• Pfizer Inc.
• RTP Company
• Sanitized AG
• Solvay SA
• Stepan Company
• Symrise AG
• Wacker Chemie AG

LIST OF FIGURES

• FIGURE 1. ANTIMICROBIAL INGREDIENTS MARKET RESEARCH PROCESS
• FIGURE 2. ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ANTIMICROBIAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ANTIMICROBIAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANTIMICROBIAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANTIMICROBIAL INGREDIENTS MARKET DYNAMICS
• TABLE 7. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY INORGANIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AUTOMOTIVE & TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BUILDING & CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEXTILE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. CANADA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. CANADA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. CHINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CHINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. INDIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. ITALY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. ITALY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. POLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. POLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. QATAR ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. QATAR ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ANTIMICROBIAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. ANTIMICROBIAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Antimicrobial Ingredients Market was valued at USD 4.42 billion in 2023, expected to reach USD 4.70 billion in 2024, and is projected to grow at a CAGR of 6.79%, to USD 7.00 billion by 2030.

The scope and definition of antimicrobial ingredients encompass compounds that inhibit the growth of microorganisms such as bacteria, viruses, and fungi. These ingredients are crucial in preserving the safety and efficacy of products in pharmaceuticals, food and beverages, personal care, and healthcare sectors. Their necessity is underscored by rising awareness of hygiene and safety, the increasing prevalence of infectious diseases, and stringent regulatory standards governing product formulations. Applications of these ingredients are broad, spanning disinfectants, preservatives, and therapeutic agents in diverse end-use industries like hospitals, food processing units, and consumer goods manufacturing. Market insights reveal that key growth influencers include the surging demand for natural and sustainable antimicrobial solutions, technological advancements in ingredient synthesis, and robust research and development activities. The COVID-19 pandemic has also augmented market demand due to heightened sanitation measures and a rise in consumer health consciousness, presenting significant opportunities for market entrants and established players to innovate and expand their product portfolios. However, the market is challenged by factors such as regulatory hurdles, the development of resistance by microorganisms against conventional antimicrobials, and the potential side effects or toxicity of some chemical-based options. Limitations are particularly pertinent in regions with stringent regulatory frameworks, which can impede product approvals and commercialization. To capitalize on growth opportunities, businesses should focus on innovative applications of natural antimicrobials, invest in research for sustainable and less toxic alternatives, and engage in strategic partnerships to expand their global reach. Furthermore, enhancing technological capabilities for improved efficacy and developing multi-functional antimicrobials can provide a competitive edge. The market is characterized by a shift towards environmentally friendly and consumer-safe products, indicating a lucrative frontier for innovation and research in biodegradable and plant-based antimicrobials.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antimicrobial Ingredients Market

The Antimicrobial Ingredients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing awareness regarding health and hygiene issues
  • Growing demand for sanitizers and surface disinfectants
  • Rise in disposable income and higher adoption of antimicrobial cosmetic products
• Market Restraints
  • Rising costs associated with raw materials and formulation of antimicrobial ingredients
• Market Opportunities
  • Inclination toward plant-based antimicrobial products
  • Launch of newly developed antimicrobial ingredients
• Market Challenges
  • Stringent approval processes of antimicrobial ingredients

Porter's Five Forces: A Strategic Tool for Navigating the Antimicrobial Ingredients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antimicrobial Ingredients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antimicrobial Ingredients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antimicrobial Ingredients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antimicrobial Ingredients Market

A detailed market share analysis in the Antimicrobial Ingredients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antimicrobial Ingredients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antimicrobial Ingredients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antimicrobial Ingredients Market

A strategic analysis of the Antimicrobial Ingredients Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Ingredients Market, highlighting leading vendors and their innovative profiles. These include Ashland Global Holdings Inc, Avient Corporation, BASF SE, BioCote Limited, Clariant AG, Croda International PLC, Destiny Pharma PLC, DuPont de Nemours, Inc., HeiQ PLC, Kemin Industries, Inc., Lonza Group AG, LyondellBasell Industries Holdings B.V., Merck KGaA, Microban International, Ltd., Milliken & Company, Momentive Performance Materials Inc, NATUREX SA, Nouryon Chemicals Holding B.V., Pfizer Inc., RTP Company, Sanitized AG, Solvay SA, Stepan Company, Symrise AG, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Inorganic and Organic.
• Based on End-User, market is studied across Automotive & Transportation, Building & Construction, Food & Beverage, Healthcare, and Textile.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing awareness regarding health and hygiene issues
    • 5.1.1.2. Growing demand for sanitizers and surface disinfectants
    • 5.1.1.3. Rise in disposable income and higher adoption of antimicrobial cosmetic products
  • 5.1.2. Restraints
    • 5.1.2.1. Rising costs associated with raw materials and formulation of antimicrobial ingredients
  • 5.1.3. Opportunities
    • 5.1.3.1. Inclination toward plant-based antimicrobial products
    • 5.1.3.2. Launch of newly developed antimicrobial ingredients
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent approval processes of antimicrobial ingredients
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Antimicrobial Ingredients Market, by Type

• 6.1. Introduction
• 6.2. Inorganic
• 6.3. Organic

7. Antimicrobial Ingredients Market, by End-User

• 7.1. Introduction
• 7.2. Automotive & Transportation
• 7.3. Building & Construction
• 7.4. Food & Beverage
• 7.5. Healthcare
• 7.6. Textile

8. Americas Antimicrobial Ingredients Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Antimicrobial Ingredients Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Antimicrobial Ingredients Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Ashland Global Holdings Inc
• 2. Avient Corporation
• 3. BASF SE
• 4. BioCote Limited
• 5. Clariant AG
• 6. Croda International PLC
• 7. Destiny Pharma PLC
• 8. DuPont de Nemours, Inc.
• 9. HeiQ PLC
• 10. Kemin Industries, Inc.
• 11. Lonza Group AG
• 12. LyondellBasell Industries Holdings B.V.
• 13. Merck KGaA
• 14. Microban International, Ltd.
• 15. Milliken & Company
• 16. Momentive Performance Materials Inc
• 17. NATUREX SA
• 18. Nouryon Chemicals Holding B.V.
• 19. Pfizer Inc.
• 20. RTP Company
• 21. Sanitized AG
• 22. Solvay SA
• 23. Stepan Company
• 24. Symrise AG
• 25. Wacker Chemie AG